Guizhou Yibai Pharmaceutical Co Ltd (600594) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.013x

Based on the latest financial reports, Guizhou Yibai Pharmaceutical Co Ltd (600594) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥33.28 Million ≈ $4.87 Million USD) by net assets (CN¥2.52 Billion ≈ $368.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Guizhou Yibai Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Guizhou Yibai Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Guizhou Yibai Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guizhou Yibai Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guizhou Yibai Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Guizhou Yibai Pharmaceutical Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Aspen Aerogels Inc NYSE:ASPN	-0.084x
RattanIndia Enterprises Limited NSE:RTNINDIA	-0.203x
Emeco Holdings Ltd AU:EHL	0.189x
KENGIC Intelligent Technology Co. Ltd. A SHG:688455	N/A
Nanhua Bio Medicine Co Ltd SHE:000504	0.062x
Shenzhen Kingsun Science Tech SHE:300235	-0.018x
Boston Omaha Corp NYSE:BOC	0.008x
LF Corp KO:093050	0.034x

Annual Cash Flow Conversion Efficiency for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Guizhou Yibai Pharmaceutical Co Ltd from 2002 to 2025. View 600594 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.27 Billion ≈ $332.26 Million	CN¥256.71 Million ≈ $37.56 Million	0.113x	+239.16%
2024-12-31	CN¥2.61 Billion ≈ $381.36 Million	CN¥86.87 Million ≈ $12.71 Million	0.033x	-73.36%
2023-12-31	CN¥3.02 Billion ≈ $441.67 Million	CN¥377.61 Million ≈ $55.26 Million	0.125x	+15.58%
2022-12-31	CN¥3.19 Billion ≈ $466.79 Million	CN¥345.30 Million ≈ $50.53 Million	0.108x	-58.72%
2021-12-31	CN¥3.56 Billion ≈ $521.30 Million	CN¥934.21 Million ≈ $136.70 Million	0.262x	+147.69%
2020-12-31	CN¥3.46 Billion ≈ $506.76 Million	CN¥366.66 Million ≈ $53.65 Million	0.106x	+8.67%
2019-12-31	CN¥3.72 Billion ≈ $544.80 Million	CN¥362.71 Million ≈ $53.08 Million	0.097x	+77.78%
2018-12-31	CN¥3.91 Billion ≈ $572.24 Million	CN¥214.30 Million ≈ $31.36 Million	0.055x	-62.69%
2017-12-31	CN¥4.64 Billion ≈ $679.20 Million	CN¥681.78 Million ≈ $99.77 Million	0.147x	+61.80%
2016-12-31	CN¥4.19 Billion ≈ $613.53 Million	CN¥380.62 Million ≈ $55.70 Million	0.091x	-43.82%
2015-12-31	CN¥3.55 Billion ≈ $519.48 Million	CN¥573.68 Million ≈ $83.95 Million	0.162x	+2.18%
2014-12-31	CN¥3.42 Billion ≈ $501.09 Million	CN¥541.58 Million ≈ $79.25 Million	0.158x	-47.05%
2013-12-31	CN¥1.93 Billion ≈ $282.78 Million	CN¥577.24 Million ≈ $84.47 Million	0.299x	+60.29%
2012-12-31	CN¥1.55 Billion ≈ $226.16 Million	CN¥288.01 Million ≈ $42.15 Million	0.186x	-23.66%
2011-12-31	CN¥1.14 Billion ≈ $166.55 Million	CN¥277.83 Million ≈ $40.65 Million	0.244x	+84.89%
2010-12-31	CN¥876.05 Million ≈ $128.19 Million	CN¥115.66 Million ≈ $16.92 Million	0.132x	-9.65%
2009-12-31	CN¥710.95 Million ≈ $104.03 Million	CN¥103.88 Million ≈ $15.20 Million	0.146x	-53.82%
2008-12-31	CN¥598.16 Million ≈ $87.53 Million	CN¥189.26 Million ≈ $27.69 Million	0.316x	+1304.16%
2007-12-31	CN¥530.04 Million ≈ $77.56 Million	CN¥11.94 Million ≈ $1.75 Million	0.023x	-89.98%
2006-12-31	CN¥425.69 Million ≈ $62.29 Million	CN¥95.77 Million ≈ $14.01 Million	0.225x	+608.46%
2005-12-31	CN¥547.39 Million ≈ $80.10 Million	CN¥17.38 Million ≈ $2.54 Million	0.032x	+135.92%
2004-12-31	CN¥506.70 Million ≈ $74.15 Million	CN¥-44.80 Million ≈ $-6.56 Million	-0.088x	-117.30%
2003-12-31	CN¥180.22 Million ≈ $26.37 Million	CN¥92.10 Million ≈ $13.48 Million	0.511x	-10.81%
2002-12-31	CN¥128.20 Million ≈ $18.76 Million	CN¥73.46 Million ≈ $10.75 Million	0.573x	--

About Guizhou Yibai Pharmaceutical Co Ltd

SHG:600594 China Drug Manufacturers - Specialty & Generic

Market Cap

$403.28 Million

CN¥2.76 Billion CNY

Market Cap Rank

#13413 Global

#3981 in China

Share Price

CN¥3.48

Change (1 day)

-4.92%

52-Week Range

CN¥2.95 - CN¥5.06

All Time High

CN¥19.64